Hassan Lamiece, Weston Jade, Senior Jane, Shaw Jenny
Lancashire Care NHS Foundation Trust, Preston, UK.
Crim Behav Ment Health. 2012 Feb;22(1):29-40. doi: 10.1002/cbm.822. Epub 2011 Sep 28.
Traditionally, medication in prison has been administered in single, supervised doses. Prisons in England and Wales, however, have now been encouraged to allow prisoners to hold and manage their own medication themselves as 'in-possession' medication, in line with community practices.
We aimed to examine the range of policies and practices used to manage in-possession medication in prisons, and to explore staff and patient perspectives.
A mixed methods design was selected. Questionnaires were sent to all prisons throughout England and Wales in 2008, and follow-up interviews were completed with 68 staff and 24 patients at 12 prisons.
In-possession medication was permitted to some degree within all prisons. Interviewees identified its principal benefit in terms of empowerment, whilst acknowledging the need to minimise health and security risks. Structured methods of risk assessment were used in 93% of establishments, although content and structure varied widely.
There is still some way to go before in-possession medication policies are fully embraced in prisons. Staff and patients recognise its benefits, but some remain uneasy around the perceived risks. Risk management processes in some establishments may still require development.
Prisoners and staff generally find it acceptable for prisoners to have their own medication in their possession, to manage themselves, unless individual risk assessment indicates otherwise. Achievement of the optimum balance between security, safety and empowering patients is difficult in practice. Robust, specific methods of risk management in relation to in-possession medication may help prisons move from being 'risk averse' to 'risk aware'.
传统上,监狱中的药物是单次监督给药的。然而,英格兰和威尔士的监狱现在被鼓励允许囚犯自行持有和管理自己的药物,即“持有式”药物,这与社区做法一致。
我们旨在研究用于管理监狱中持有式药物的政策和做法范围,并探讨工作人员和患者的观点。
选择了混合方法设计。2008年向英格兰和威尔士的所有监狱发送了问卷,并对12所监狱的68名工作人员和24名患者进行了后续访谈。
所有监狱在一定程度上都允许持有式药物。受访者认为其主要好处在于赋予权力,同时承认需要将健康和安全风险降至最低。93%的机构使用了结构化风险评估方法,尽管内容和结构差异很大。
在监狱中全面采用持有式药物政策仍有一段路要走。工作人员和患者认识到其好处,但一些人对感知到的风险仍感到不安。一些机构的风险管理流程可能仍需改进。
囚犯和工作人员通常认为囚犯持有自己的药物并自行管理是可以接受的,除非个人风险评估另有指示。在实践中,要在安全、保障和赋予患者权力之间实现最佳平衡是困难的。与持有式药物相关的稳健、具体的风险管理方法可能有助于监狱从“规避风险”转变为“风险意识强”。